Latest news with #Slingshot
Yahoo
12 hours ago
- Business
- Yahoo
Butler, Hamilton counties seize large amounts of fentanyl and cocaine
Jun. 5—A three-month narcotics trafficking investigation netted the seizure of a large amount of fentanyl and cocaine. At around 7 a.m. Thursday, the Butler County Undercover Regional Narcotics Task Force searched an apartment in the 5200 block of Camelot Drive in Fairfield. Later, with the support of the Hamilton County Drug Abuse Taskforce, authorities searched an apartment in the 2300 block of Hidden Meadows Drive in Springfield. The investigation ended with the arrest of Errol Baker, 42, who is being held in the Butler County Jail on two first-degree felony counts of drug possession. He was arrested in Fairfield and is held on a $500,000 bond. Officer recovered from the two apartments about 120 grams of fentanyl, which could kill as many as 60,000 people; more than 90 grams of cocaine, $5,400, a 2017 Mercedes-Benz vehicle, and a Slingshot motorcycle. "This case represents the continued dedication of the BURN Task Force to identifying and removing high-level drug traffickers from our communities," said Butler County Sheriff Richard Jones. "Fentanyl is a deadly poison, and those who profit from its distribution will be held accountable."
Yahoo
12 hours ago
- Yahoo
Butler, Hamilton counties seize large amounts of fentanyl and cocaine
Jun. 5—A three-month narcotics trafficking investigation netted the seizure of a large amount of fentanyl and cocaine. At around 7 a.m. Thursday, the Butler County Undercover Regional Narcotics Task Force searched an apartment in the 5200 block of Camelot Drive in Fairfield. Later, with the support of the Hamilton County Drug Abuse Taskforce, authorities searched an apartment in the 2300 block of Hidden Meadows Drive in Springfield. The investigation ended with the arrest of Errol Baker, 42, who is being held in the Butler County Jail on two first-degree felony counts of drug possession. He was arrested in Fairfield and is held on a $500,000 bond. Officer recovered from the two apartments about 120 grams of fentanyl, which could kill as many as 60,000 people; more than 90 grams of cocaine, $5,400, a 2017 Mercedes-Benz vehicle, and a Slingshot motorcycle. "This case represents the continued dedication of the BURN Task Force to identifying and removing high-level drug traffickers from our communities," said Butler County Sheriff Richard Jones. "Fentanyl is a deadly poison, and those who profit from its distribution will be held accountable."
Yahoo
16 hours ago
- Yahoo
Fentanyl, luxury vehicles seized in Ohio drug bust
[Watch in the player above: What is fentanyl?] HAMILTON, Ohio (WJW) — Authorities said they seized enough fentanyl to kill tens of thousands of people as well as a luxury car and motorcycle in a drug bust early Thursday, June 5. Butler County Sheriff Richard Jones said the region's undercover narcotics task force executed two search warrants at two Ohio homes — one in Fairfield, Butler County, and another in Springdale, Hamilton County — following a three-month drug trafficking investigation, according to a Facebook post. 6-year-old boy dies tragically in rare balloon suffocation accident, coroner says Agents seized about 120 grams of fentanyl, a little more than a quarter-pound — enough to kill 60,000 people, according to the post — 90 grams of cocaine and $5,400 in cash. They also seized a 2017 Mercedes-Benz sedan and a Slingshot three-wheeled motorcycle: Multiple inmates overdose at Mansfield prison Errol Baker, 42, was arrested and charged with two first-degree felony counts of possession of drugs. He remains in the Butler County jail, according to the post. 'This case represents the continued dedication of the B.U.R.N. Task Force to identifying and removing high-level drug traffickers from our communities,' Jones is quoted in the post. 'Fentanyl is a deadly poison, and those who profit from its distribution will be held accountable.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
28-05-2025
- Business
- Business Wire
Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets
EMERYVILLE, Calif.--(BUSINESS WIRE)--Slingshot Biosciences, a leader in precision-engineered cell mimics, has appointed Glenn Bilawsky as Chief Executive Officer. He succeeds Founder and former CEO Jeffrey Kim, PhD, who will remain actively involved as a Senior Advisor and Board Director. This transition is a strategic inflection point as Slingshot scales to meet rising global demand for cell mimics as standardized, reliable alternatives to biological controls. The widespread adoption of its TruCytes™ and SpectraComp ® products across research, clinical trials, diagnostics, and cell therapy applications is driving the company to expand its commercial footprint, industry partnerships, and advance regulatory-grade solutions. 'Slingshot is transforming how scientists in diagnostic, and therapeutic research and development access and apply cellular controls,' said Glenn Bilawsky, CEO. 'Jeff has built a remarkable company rooted in scientific excellence. I'm excited to build on that foundation—scaling the commercial team and focusing our portfolio to ensure our solutions maintain their position as the gold standard of cell-based controls used in regulated and research workflows.' Bilawsky brings decades of success and leadership in scaling life science, contract research, and analytical laboratory service companies focused on biomarker development. His appointment will accelerate Slingshot's momentum and the achievement of its mission to replace traditional biological reference materials with scalable, customizable and cost-effective cell mimic controls. Dr. Kim, who invented and led the development of Slingshot's core technologies, emphasized continuity in the company's mission: 'I'm proud of how far Slingshot has come. Glenn brings a remarkable track record of success and his leadership will unlock our next phase of growth. I am committed to the continued support of the company and look forward to working with Glenn in this next phase of the business.' About Slingshot Biosciences Slingshot Biosciences develops cell mimics for a range of applications in diagnostics and therapeutics. Slingshot leverages advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf customizable solution for cell-like reagents that are stable and targeted toward a range of indications and markets.
Yahoo
28-05-2025
- Business
- Yahoo
Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets
EMERYVILLE, Calif., May 28, 2025--(BUSINESS WIRE)--Slingshot Biosciences, a leader in precision-engineered cell mimics, has appointed Glenn Bilawsky as Chief Executive Officer. He succeeds Founder and former CEO Jeffrey Kim, PhD, who will remain actively involved as a Senior Advisor and Board Director. This transition is a strategic inflection point as Slingshot scales to meet rising global demand for cell mimics as standardized, reliable alternatives to biological controls. The widespread adoption of its TruCytes™ and SpectraComp® products across research, clinical trials, diagnostics, and cell therapy applications is driving the company to expand its commercial footprint, industry partnerships, and advance regulatory-grade solutions. "Slingshot is transforming how scientists in diagnostic, and therapeutic research and development access and apply cellular controls," said Glenn Bilawsky, CEO. "Jeff has built a remarkable company rooted in scientific excellence. I'm excited to build on that foundation—scaling the commercial team and focusing our portfolio to ensure our solutions maintain their position as the gold standard of cell-based controls used in regulated and research workflows." Bilawsky brings decades of success and leadership in scaling life science, contract research, and analytical laboratory service companies focused on biomarker development. His appointment will accelerate Slingshot's momentum and the achievement of its mission to replace traditional biological reference materials with scalable, customizable and cost-effective cell mimic controls. Dr. Kim, who invented and led the development of Slingshot's core technologies, emphasized continuity in the company's mission: "I'm proud of how far Slingshot has come. Glenn brings a remarkable track record of success and his leadership will unlock our next phase of growth. I am committed to the continued support of the company and look forward to working with Glenn in this next phase of the business." About Slingshot Biosciences Slingshot Biosciences develops cell mimics for a range of applications in diagnostics and therapeutics. Slingshot leverages advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf customizable solution for cell-like reagents that are stable and targeted toward a range of indications and markets. View source version on Contacts Brint Rodenpr@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
